Use of rHuG-CSF in myelodysplastic syndromes

Mojtaba Akhtari; Lori Maness

doi:10.1007/978-3-0348-0218-5_10

Use of rHuG-CSF in myelodysplastic syndromes

Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	American English
Title of host publication	Twenty Years of G-CSF
Subtitle of host publication	Clinical and Nonclinical Discoveries
Editors	Graham Molineux, Tara Arvedson, MaryAnn Foote
Pages	183-193
Number of pages	11
DOIs	https://doi.org/10.1007/978-3-0348-0218-5_10 https://doi.org/10.1007/978-3-0348-0218-5_10
State	Published - 2012

Publication series

Name	Milestones in Drug Therapy
Volume	43

ASJC Scopus Subject Areas

Drug Discovery
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Disciplines

Gastroenterology
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1007/978-3-0348-0218-5_10License: Unspecified
10.1007/978-3-0348-0218-5_10

OpenUrl availability

Full text

Cite this

@inbook{c3507c5836f74271945a185739117ba4,

title = "Use of rHuG-CSF in myelodysplastic syndromes",

author = "Mojtaba Akhtari and Lori Maness",

note = "Mojtaba Akhtari Lori Maness Part of the Milestones in Drug Therapy book series (MDT) The myelodysplastic syndromes (MDS) represent a series of clonal hematologic neoplasm characterized by morphologic dysplasia, aberrant hematopoiesis, and peripheral blood refractory cytopenias.",

year = "2012",

doi = "10.1007/978-3-0348-0218-5_10",

language = "American English",

isbn = "9783034802178",

series = "Milestones in Drug Therapy",

pages = "183--193",

editor = "Graham Molineux and Tara Arvedson and { Foote}, MaryAnn",

booktitle = "Twenty Years of G-CSF",

}

TY - CHAP

T1 - Use of rHuG-CSF in myelodysplastic syndromes

AU - Akhtari, Mojtaba

AU - Maness, Lori

N1 - Mojtaba Akhtari Lori Maness Part of the Milestones in Drug Therapy book series (MDT) The myelodysplastic syndromes (MDS) represent a series of clonal hematologic neoplasm characterized by morphologic dysplasia, aberrant hematopoiesis, and peripheral blood refractory cytopenias.

PY - 2012

Y1 - 2012

UR - https://link.springer.com/chapter/10.1007/978-3-0348-0218-5_10

U2 - 10.1007/978-3-0348-0218-5_10

DO - 10.1007/978-3-0348-0218-5_10

M3 - Chapter

SN - 9783034802178

T3 - Milestones in Drug Therapy

SP - 183

EP - 193

BT - Twenty Years of G-CSF

A2 - Molineux, Graham

A2 - Arvedson, Tara

A2 - Foote, MaryAnn

ER -

Use of rHuG-CSF in myelodysplastic syndromes

Publication series

ASJC Scopus Subject Areas

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this